PharmiWeb.com - Global Pharma News & Resources
31-Jan-2019

Beleave Awarded ISO 9001:2015 Certification as Part of Ongoing Commitment to Improve Efficiency

TORONTO, Jan. 31, 2019 /PRNewswire/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that its wholly-owned subsidiary, Beleave Kannabis Corporation, has obtained ISO 9001:2015 Certification for the research, development, and production of cannabis products for medicinal and recreational purposes at its Hamilton, Ontario facility.

ISO 9001 is a quality management system standard developed by the International Organization for Standardization, an association of governmental and nongovernmental organizations from many countries.

ISO 9001:2015 is the most up-to-date standard of its kind and contains key updates, including an emphasis on risk-based thinking to enhance the application of the process approach, improved applicability for services, and increased leadership requirements. Achievement of this certification shows Beleave's commitment to high quality products, customer satisfaction, and continuous improvement. Common benefits of being certified reported by the ISO include improved efficiency, cost savings, and a higher level of customer service.

"After many months of hard work and preparation, we are extremely proud to be one of the few licensed producers of cannabis to have received ISO 9001:2015 accreditation," commented Roger Ferreira, Beleave's Chief Science Officer. "This certification reflects Beleave's ongoing commitment to quality across key elements of our business, which includes research, innovation, and production of cannabis products. Further, this internationally recognized certification for our quality management system positions us well as we continue to develop international partnerships and plan to enter global markets."

Beleave Kannabis Corporation was certified to the ISO 9001:2015 standard by Bureau Veritas Certification Holding SAS on January 25, 2019.

ABOUT ISO
ISO (International Organization for Standardization) is an independent, non-governmental international organization with a membership of 162 national standards bodies. Through its members, it brings together experts to share knowledge and develop voluntary, consensus-based, market relevant International Standards that support innovation and provide solutions to global challenges. ISO has published 22008 International Standards and related documents, covering almost all aspects of technology and manufacturing.

ABOUT BELEAVE INC.
Beleave is a vertically-integrated, ISO 9001:2015 certified, Canadian cannabis company headquartered in Oakville, Ontario, that cultivates high-quality cannabis flower, oil and extracts.

Beleave is fully-licenced to cultivate and sell medical and recreational cannabis and is leading the way through research partnerships with universities to develop pharma-grade extracts and derivatives. Beleave has developed new product lines, including cannabis-infused powder and sugar products for 2019 as the recreational market is expected to allow for food and beverage-based cannabis products.

Beleave has also developed a network of medical cannabis clinics in Ontario and Quebec under the Medi-Green banner. Through its majority ownership of Procannmed S.A.S., Beleave is fully licensed to cultivate, produce, extract and distribute medical cannabis in Colombia to capitalize on exports and the expanding Latin American market. In a strategic initiative to penetrate the European medical market, the Company has partnered with Canymed GmbH to supply the German market with medical cannabis.

Forward-Looking Statements

This news release contains "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). The use of any of the words "plan", "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and other similar words, or statements that certain events or conditions "may" or "will" occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speaks only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents, which can be found under the Company's profile on www.sedar.com.

Editor Details

Last Updated: 31-Jan-2019